Diasorin SpA (MIL:DIA) Net Margin % : 16.67% (As of Jun. 2024)

View and export this data going back to 2007. Start your Free Trial

What is Diasorin SpA Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Diasorin SpA's Net Income for the three months ended in Jun. 2024 was €50 Mil. Diasorin SpA's Revenue for the three months ended in Jun. 2024 was €300 Mil. Therefore, Diasorin SpA's net margin for the quarter that ended in Jun. 2024 was 16.67%.

The historical rank and industry rank for Diasorin SpA's Net Margin % or its related term are showing as below:

MIL:DIA' s Net Margin % Range Over the Past 10 Years
Min: 13.92 Med: 21.03 Max: 28.13
Current: 16.03

MIL:DIA's Net Margin % is ranked better than
87.91% of 215 companies
in the Medical Diagnostics & Research industry
Industry Median: -10.68 vs MIL:DIA: 16.03

Diasorin SpA Net Margin % Historical Data

The historical data trend for Diasorin SpA's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Diasorin SpA Net Margin % Chart

Diasorin SpA Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Net Margin %

Get a 7-Day Free Trial

24.88

28.13

25.13

17.70

13.92

Diasorin SpA Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Net Margin %	Get a 7-Day Free Trial															9.26	15.83	15.92	16.67	15.68

Competitive Comparison of Diasorin SpA's Net Margin %

For the Diagnostics & Research subindustry, Diasorin SpA's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Diasorin SpA's Net Margin % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Diasorin SpA's Net Margin % distribution charts can be found below:

* The bar in red indicates where Diasorin SpA's Net Margin % falls into.

Diasorin SpA Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Diasorin SpA's Net Margin for the fiscal year that ended in Dec. 2023 is calculated as

Net Margin	=	Net Income (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	159.849	/	1148.21
	=	13.92 %

Diasorin SpA's Net Margin for the quarter that ended in Jun. 2024 is calculated as

Net Margin	=	Net Income (Q: Jun. 2024 )	/	Revenue (Q: Jun. 2024 )
	=	50	/	300
	=	16.67 %

Diasorin SpA (MIL:DIA) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Diasorin SpA Net Margin % Related Terms

Thank you for viewing the detailed overview of Diasorin SpA's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Diasorin SpA Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Diasorin SpA (MIL:DIA) » Definitions » Net Margin %

Comparable Companies

Traded in Other Exchanges

DIAm:UK 0GZX:UK 34D:Germany DIAS:Austria

Address

Via Crescentino Snc, Saluggia, Vercelli, ITA, 13040

Website

https://www.diasoringroup.com

DiaSorin, headquartered in Italy, is a global provider of in vitro diagnostics, or IVD, which refers to testing done on samples taken from the human body, such as blood and tissue. DiaSorin produces and markets testing reagent kits for immunodiagnostics (about 65% of total sales) and molecular diagnostics (about 20%) and has a total installed base of about 9,000 diagnostic systems. Instruments and other revenue contribute about 15% of total sales. DiaSorin's largest market in 2023 was North America, which accounted for 48% of non-covid revenue, followed by Europe (35%) and the Rest of the World (18%).